Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
Clinical trial NCT04864379 · UNKNOWN
Trial details
- NCT number
- NCT04864379
- Sponsor
- Sir Run Run Shaw Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2025-08-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.